SCHEMBL5482956

SCHEMBL5482956

O=C(O)N1CCN(CCc2cccc3ccccc23)CC1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.57
ADRA1D P25100 5/20 0.53
ADRA1A P35348 5/20 0.53
ADRA1B P35368 5/20 0.53
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
OPRK1 P41145 1/20 0.48
SIGMAR1 Q99720 2/20 0.48
KDM4E B2RXH2 2/20 0.48
ALDH1A1 P00352 2/20 0.48
HSD17B10 Q99714 2/20 0.48
USP2 O75604 1/20 0.48
LMNA P02545 1/20 0.48
ALOX15 P16050 1/20 0.48
MAPK1 P28482 1/20 0.48
TDP1 Q9NUW8 1/20 0.47
KCNH2 Q12809 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16673587 0.85 FAAH (0.71) FAAHMEN1KMT2AKDM4EALDH1A1
SCHEMBL17444633 0.81 MTNR1A (0.58)
SCHEMBL18889424 0.81 ACHE (0.56) FAAHADRA1DADRA1AADRA1BKMT2A
SCHEMBL9232873 0.80 HRH3 (0.59) ADRA1DADRA1AADRA1BSIGMAR1TDP1
SCHEMBL1514830 0.79 HTR2A (0.58) MEN1KMT2ASIGMAR1KDM4EALDH1A1
SCHEMBL1581739 0.78 SLC18A2 (0.49) MEN1KMT2AKDM4ETDP1
SCHEMBL16358059 0.78 ADRA1D (0.56) ADRA1DADRA1AADRA1BSIGMAR1LMNA
SCHEMBL3936968 0.78 DRD4 (0.63) ADRA1DADRA1AADRA1BSIGMAR1KDM4E
SCHEMBL2177229 0.77 KMT2A (0.53) FAAHADRA1DADRA1AADRA1BKMT2A
SCHEMBL2927709 0.77 MEN1 (0.73) FAAHMEN1KMT2ASIGMAR1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1720848-B1 DERIVATIVES OF ALKYLPIPERAZINE- AND ALKYLHOMOPIPERAZINE- CARBOXYLATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FAAH ENZYME INHIBITORS SANOFI AVENTIS (FR) 2007-12-05 EP claimed
EP-3169683-A1 FUNCTIONALISED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS Novogen Ltd. (AU) 2017-05-24 EP disclosed
WO-2016008011-A1 FUNCTIONALISED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS Novogen ltd (AU) 2016-01-21 WO disclosed
EP-1720848-B1 DERIVATIVES OF ALKYLPIPERAZINE- AND ALKYLHOMOPIPERAZINE- CARBOXYLATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FAAH ENZYME INHIBITORS SANOFI AVENTIS (FR) 2007-12-05 EP disclosed
EP-1720848-A1 DERIVATIVES OF ALKYLPIPERAZINE- AND ALKYLHOMOPIPERAZINE- CARBOXYLATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FAAH ENZYME INHIBITORS Sanofi-Aventis (FR) 2006-11-15 EP disclosed
WO-2005090322-A1 DERIVATIVES OF ALKYLPIPERAZINE- AND ALKYLHOMOPIPERAZINE- CARBOXYLATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FAAH ENZYME INHIBITORS SANOFI-AVENTIS (FR) 2005-09-29 WO disclosed